Captor Therapeutics Spolka Akcyjna
CTX.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 223 | PLN 186 | PLN 214 | PLN 232 |
| - Cash | PLN 4 | PLN 15 | PLN 17 | PLN 39 |
| + Debt | PLN 4 | PLN 1 | PLN 5 | PLN 6 |
| Enterprise Value | PLN 223 | PLN 172 | PLN 202 | PLN 199 |
| Revenue | PLN 0 | PLN 2 | PLN 3 | PLN 3 |
| % Growth | -100% | -22.9% | -11.8% | – |
| Gross Profit | PLN 2 | -PLN 1 | PLN 2 | PLN 1 |
| % Margin | – | -29% | 66.5% | 27.3% |
| EBITDA | -PLN 10 | -PLN 9 | -PLN 9 | -PLN 8 |
| % Margin | – | -469.3% | -360.3% | -254.3% |
| Net Income | -PLN 11 | -PLN 10 | -PLN 11 | -PLN 9 |
| % Margin | – | -485.3% | -411.3% | -296.5% |
| EPS Diluted | -2.08 | -1.77 | -1.95 | -1.59 |
| % Growth | -17.5% | 9.2% | -22.6% | – |
| Operating Cash Flow | -PLN 12 | -PLN 11 | PLN 23 | -PLN 8 |
| Capital Expenditures | PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 12 | -PLN 11 | PLN 23 | -PLN 9 |